Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
NASDAQ:MLAB
Price:
105.52 USD
2.26%
Market Closed
Updated:
Apr 30, 2024
Mesa Laboratories Inc
Cash from Financing Activities
|
Mesa Laboratories Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Cash from Financing Activities
$41.4m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Mesa Laboratories Inc's Cash from Financing Activities?
Cash from Financing Activities
41.4m
USD
41.4m
USD
Based on the financial report for Dec 31, 2023, Mesa Laboratories Inc's Cash from Financing Activities amounts to 41.4m USD.
What is Mesa Laboratories Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
15%
15%
The average annual Cash from Financing Activities growth rates for Mesa Laboratories Inc have been -35% over the past three years , and 15% over the past ten years .
You don't have any saved screeners yet
